Loading…
Biofil Chemicals & Pharmaceuticals (BIOFILCHEM)₹30.51−1.36%Pharmaceuticals
Biofil Chemicals & Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 18.3 against a peer median of 7.9, and ROCE of 15.8% against a peer median of 12.1%, and latest-quarter sales growth of −9.2% against a peer median of −9.2%. By market cap it is #3 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunrest Lifescience | 61 | 7.4 | 28.5 | 22.4 | 0.86 | 0.0 | 71 | 8 | — | — | vs BIOFILCHEM |
| Phaarmasia | 54 | 3.1 | 15.9 | 12.9 | 0.05 | 0.0 | 47 | 18 | 42.3 | — | vs BIOFILCHEM |
| Biofil Chemicals & Pharmaceuticals | 50 | 18.3 | 15.8 | 13.8 | 0.14 | 0.0 | 28 | 3 | −9.2 | 5.3 | — |
| Parmax Pharma | 49 | — | −82.9 | — | — | 0.0 | 12 | −4 | −31.5 | — | vs BIOFILCHEM |
| ANG Lifesciences India | 48 | — | −4.0 | −18.9 | 1.50 | 0.0 | 93 | −11 | −37.8 | — | vs BIOFILCHEM |
| Mangalam Drugs and Organics | 46 | — | −14.0 | −35.1 | 1.02 | 0.0 | 232 | −44 | −0.2 | — | vs BIOFILCHEM |
| Vivimed Labs | 45 | — | −65.0 | — | — | 0.0 | 70 | −176 | −53.8 | — | vs BIOFILCHEM |
| Vasundhara Rasayans | 44 | 7.4 | 20.2 | 15.2 | 0.04 | 1.5 | 36 | 6 | 53.1 | 441.3 | vs BIOFILCHEM |
| Chandra Bhagat Pharma | 43 | 14.3 | 12.1 | 9.6 | 0.50 | 0.0 | 116 | 3 | 313.6 | — | vs BIOFILCHEM |
| Kabra Drugs | 42 | 8.4 | 20.8 | 18.3 | 0.02 | 0.0 | 93 | 5 | — | 167.5 | vs BIOFILCHEM |
| Vista Pharmaceuticals | 41 | — | −30.0 | −29.5 | 0.27 | 0.0 | 5 | −12 | −100.0 | — | vs BIOFILCHEM |
| Peer median | 46 | 7.9 | 12.1 | 12.9 | 0.27 | 0.0 | 70 | 3 | −9.2 | 167.5 |
Listed companies closest to Biofil Chemicals & Pharmaceuticals in Pharmaceuticals include Sunrest Lifescience, Phaarmasia, Parmax Pharma, ANG Lifesciences India, Mangalam Drugs and Organics, Vivimed Labs, Vasundhara Rasayans, Chandra Bhagat Pharma.
Sunrest Lifescience, with a market cap of ₹61.40 Cr.
Biofil Chemicals & Pharmaceuticals trades at a P/E of 18.3; the median of its peer set is 7.9. A P/E above or below the median is a description, not a judgement on value.
Biofil Chemicals & Pharmaceuticals' return on capital employed is 15.8%, above the peer median of 12.1%.